جست‌وجوی استاد و پژوهشگر

• Neuroscience
• Anesthesiology
• Brain Imaging
• +۳ مورد دیگر

Dr. Helene Benveniste is a Professor of Anesthesiology at Yale School of Medicine, specializing in neuroimaging and neurodegenerative diseases. She holds a dual background in Mathematics/Physics (BSc, Katedralskolen) and Medicine (MD and PhD in Neurobiology from University of Copenhagen). Her research focuses on the glymphatic system, cerebrospinal fluid dynamics, and brain waste clearance in aging and neurodegenerative diseases like Alzheimer’s. She has pioneered MRI/PET techniques for studying these processes and contributed to understanding cerebral amyloid angiopathy. Affiliations include the Anesthesiology Department, Yale Biomedical Imaging Institute, and the Center for Brain & Mind Health. Collaborators include Douglas Rothman, D. S. Fahmeed Hyder, and Kevin Behar. Her work spans clinical trials (e.g., SEMALCO trial for alcohol use disorder) and translational research, with over 100 publications. Notable 2025 studies address brain aging, CSF pathways, and glymphatic transport mechanisms. Education: • PhD in Neurobiology, University of Copenhagen (1991) • MD, University of Copenhagen (1986) Research Interests: • Glymphatic system function and dysfunction • Cerebrospinal fluid dynamics in health/disease • Neuroimaging techniques (MRI/PET) • Alzheimer’s and other neurodegenerative diseases • Brain clearance pathways in aging Publications Trends: Recent work emphasizes brain aging, CSF transport, and translational applications like clinical trials for alcohol use disorder. Key themes include glymphatic system dysfunction in neurodegeneration, fluid dynamics modeling, and biomarker discovery. Labs/Teams: Leads a research lab at Yale investigating glymphatic pathways and their role in disease. Collaborates with engineering and mathematics teams to model fluid flows using optimal mass transport algorithms.

Lisa M. Coussensمشاهده پروفایل

استاد

• Tumor Immunology
• Cancer Microenvironment
• Inflammation in Cancer
• +۳ مورد دیگر

Lisa M. Coussens, PhD, is Chairwoman of the Department of Cell, Developmental & Cancer Biology and Interim Director of the Knight Cancer Institute at Oregon Health & Science University (OHSU), where she holds the Hildegard Lamfrom Endowed Chair in Basic Science. Her research program investigates immune cell functions in solid tumor development, with emphasis on how leukocytes influence cancer progression and therapeutic responses. Using preclinical models of mesothelioma, breast, pancreatic, and head/neck cancers, her lab identifies immunotherapy targets that have advanced to clinical trials for metastatic cancers. Education B.A., San Francisco State University, 1980 Ph.D., University of California, 1993 Postdoctoral Fellowship, University of California San Francisco (Douglas Hanahan Lab) Research Focus Dr. Coussens leads a translational research program examining how immune cells regulate tumor development and therapy responses. Her work integrates molecular oncology, immunology, and preclinical modeling to identify: 1) Immune pathways co-opted by developing tumors, 2) Mechanisms of leukocyte-mediated therapy resistance, and 3) Biomarkers for immunotherapy response. Current work emphasizes spatial analysis of tumor-immune interactions using multiplexed imaging and computational approaches. Her recent publications reflect strong emphasis on tumor microenvironment dynamics, immunotherapy mechanisms, and translational applications in pancreatic, breast, and head/neck cancers. Studies frequently incorporate spatial biology techniques, clinical correlation analyses, and novel therapeutic combinations targeting immune pathways. Honors & Awards National Academy of Sciences Member (2023) National Academy of Medicine Member (2024) AACR President (2022-2023) Susan G. Komen Brinker Award (2018) Fellow of AACR Academy (2019) Fellow of AAAS (2018) Rosalind E. Franklin Award, NCI (2015) Honorary Doctorate, University of Buenos Aires (2018) Princess Takamatsu Memorial Lectureship (2018) European Academy of Tumor Immunology Career Award (2018) Gertrude B. Elion Award (2001) Charlotte Friend Lectureship (2012) Margaret L. Kripke Legend Award (2023) Johns Hopkins Heroine of Public Health (2024) Fellow of Academy of ImmunoOncology (2022) Dr. Coussens directs translational research programs at OHSU's Knight Cancer Institute and leads multidisciplinary collaborations investigating tumor-immune crosstalk. Her laboratory develops innovative preclinical platforms for evaluating combination immunotherapies.

Cheryl Ewingمشاهده پروفایل

دانشیار

• Breast Cancer Surgery
• Surgical Oncology
• Quality of Care
• +۴ مورد دیگر

Dr. Cheryl Ewing is an Associate Professor of Surgery at the University of California San Francisco (UCSF) Mount Zion Hospital , specializing in breast cancer surgery and sentinel lymph node dissection . Her research explores quality of life disparities among breast cancer survivors, particularly in minority populations, and strategies to customize treatment based on individual patient profiles. University of Michigan, Ann Arbor, BS 1974, Zoology Wayne State University, MD 1983, Medicine University of Michigan Medical School, Residency 1983-1988, Surgery University of Chicago, Fellowship 1988-1991, Surgical Oncology Her research focuses on post-surgery symptom management , barriers to medical care for minority women , and long-term oncological outcomes . Recent studies, such as those in the I-SPY2 Trial, highlight her work on neoadjuvant therapy , mastectomy margin management , and breast reconstruction techniques . Dr. Ewing's publications emphasize invasive lobular carcinoma outcomes, lymph node evaluation via MRI, and health disparities in treatment. Her recent articles (2025-2020) span topics from obesity in oncology to clinical trial design . Susan G. Komen Local Hero Award American Association of Cancer Research Travel Award Women in Medicine Professional Development Travel Award (1992) Young Surgical Investigator Travel Award - American College of Surgeons (2000) Teaching Award - University of New Mexico Dr. Ewing actively mentors residents and fellows , serves on major surgical societies , and contributes to clinical guidelines through her work with the I-SPY2 Trial and other collaborative efforts.

Yuichi Moriمشاهده پروفایل

استاد

• Gastroenterology
• Artificial Intelligence in Medicine
• Colorectal Cancer Detection
• +۳ مورد دیگر

Professor Yuichi Mori is a leading academic at the University of Oslo , affiliated with the Faculty of Medicine and the Department of Health Management and Health Economics . He serves as a Consultant Gastroenterologist at Oslo University Hospital and a Visiting Lecturer at Showa University Northern Yokohama Hospital in Japan. His work focuses on the implementation of artificial intelligence in clinical gastroenterology , particularly in colonoscopy and colorectal cancer detection.

Geir Andre Ringstadمشاهده پروفایل

دانشیار

• Neuroimaging
• Cerebrospinal Fluid Dynamics
• Glymphatic System
• +۳ مورد دیگر

Geir Andre Ringstad is an Associate Professor at the Department of Radiology and Nuclear Medicine , University of Oslo, specializing in neuroimaging and cerebrospinal fluid (CSF) dynamics . His research focuses on the glymphatic system , CSF tracer studies , and MRI-based quantification of brain clearance mechanisms. Research Themes Neurofluid dynamics and glymphatic dysfunction in normal pressure hydrocephalus , Chiari malformation , and pineal cysts Impact of sleep deprivation on CSF tracer clearance Novel MRI protocols for assessing CSF disorders and neuroimmune interfaces Publications cover diverse topics including glymphatic-lymphatic coupling , CSF flow modeling , contrast agent safety , and computational analysis of neurofluid pathways. Collaborative work spans neurosurgery , endocrinology , and biophysics .

Thomas Dayمشاهده پروفایل

پژوهشگر ارشد

• Artificial Intelligence
• Fetal Echocardiography
• Congenital Heart Disease
• +۵ مورد دیگر

Thomas Day is a Clinical Research Fellow at King's College London's School of Biomedical Engineering & Imaging Sciences, Department of Cardiovascular Imaging. He works within the Intelligent Fetal Imaging and Diagnosis (iFIND) project and practices clinically at The Evelina London Children's Hospital, part of Guy's and St Thomas' NHS Foundation Trust. Education: MBChB in Medicine, University of Manchester (2002-2008) MRes (intercalated) in Medicine, University of Manchester (2006-2008) His research focuses on leveraging artificial intelligence to enhance congenital heart disease screening through fetal echocardiography and ultrasound imaging. Key contributions include developing AI-driven tools for fetal biometric estimation, lymphatic perfusion segmentation, echocardiogram synthesis, and outlier detection in medical imaging. Scientific Awards: KHP Clinical Research Excellence Fellow Research Projects: Randomised controlled trial of AI-assisted fetal ultrasound (NIHR, 2025-2027) AI in Sub-Saharan Africa echocardiography (NIH, 2023-2025) Antenatal congenital heart disease detection (NIHR, 2021-2024)

Christopher Porterمشاهده پروفایل

استاد

• Oral Drug Delivery
• Bioavailability Enhancement
• Lymphatic Drug Transport
• +۵ مورد دیگر

Christopher Porter is the Sir John Monash Distinguished Professor and Director of the Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University. He holds fellowships with the American Association of Pharmaceutical Scientists and the Royal Australian Chemical Institute. His research focuses on drug delivery systems, lymphatic transport, and nanomedicines, with significant contributions to lipid-based formulations and dendrimer technologies. Key achievements include the Glyph® lymphatic targeting platform (Phase 2 clinical trial) and the DEP® dendrimer system (Phase 2 clinical trial). Education: Undergraduate and graduate studies at the University of Nottingham. Key Awards: Clarivate Highly Cited Researcher (2015–2024), APSA Medal (2017), Honorary Doctorate (Uppsala University, 2018). Research interests span oral bioavailability enhancement, lipid-modified drug systems, and translational drug delivery. His work has generated over $30M in funding and 15+ patent families. Notable collaborations include PureTech Health/Seaport Therapeutics and Starpharma.

Raja Shaikhمشاهده پروفایل

استادیار

• Vascular Anomalies
• Pediatric Interventional Oncology
• Minimally Invasive Radiology
• +۲ مورد دیگر

Raja Shaikh, MBBS, DNB, MD, serves as an Attending Physician at the Vascular Anomalies Center and Director of Pediatric Interventional Oncology at the Division of Vascular and Interventional Radiology. He is an Assistant Professor of Radiology at Harvard Medical School, specializing in minimally invasive, image-guided treatments for pediatric patients. Education Medical School: Jawaharlal Nehru Medical College (1999) Internship: KLE Hospital/Jawaharlal Nehru Medical College (2000) Residency: Jawaharlal Nehru Medical College (2005) Fellowship: Body MRI at University of Arkansas Medical Sciences (2010) Fellowship: Vascular and Interventional Radiology at Beth Israel Deaconess Medical Center (2011) Fellowship: Pediatric Interventional Radiology at Boston Children's Hospital (2012) Research Focus Dr. Shaikh's research concentrates on vascular anomalies and interventional oncology, including: Endovascular approaches for arteriovenous malformations Minimally invasive treatments for aneurysmal bone cysts Cryoablation applications in vascular anomalies Pediatric interventional oncology for relapsed solid tumors Scientific Contributions His publications span: Pediatric lymphatic interventions MRI-based vascular anomaly analysis Cryoablation techniques Post-operative lymphatic leak management Image-guided tumor biopsies and treatments Contact Information Phone: 617-355-6286 Fax: 617-730-0541 Email: Raja.Shaikh@childrens.harvard.edu NPI: 1477888204

Santosh Kumarمشاهده پروفایل

استاد

• Mobile Health (mHealth)
• Artificial Intelligence for Wearables
• Wireless Sensor Networks
• +۴ مورد دیگر

Dr. Santosh Kumar is a Professor and Lillian & Morrie Moss Chair of Excellence in Computer Science at the University of Memphis. He leads the NIH mDOT Center and MD2K Center of Excellence, focusing on mobile health (mHealth) and wearable AI. His research develops computational models to infer health behaviors from sensor data, with applications in stress, smoking cessation, oral hygiene, and cocaine use detection. Education: PhD in Computer Science from The Ohio State University (2006). Notable awards include Popular Science's 'Brilliant Ten' (2010), Early Career Research Award (2008), and Tennessee’s first state-endowed Chair of Excellence (2015). Research spans sensor-based biomarkers, privacy risks in mHealth, and interventions. He oversees $18M in NIH/NSF grants, involving 20+ institutions. Key projects include AutoSense and mCerebrum sensor platforms, and the mDOT Center for temporally-precise interventions. Collaborates with experts in computing, medicine, and behavioral science. Advises over 20 students, many now in tech leadership roles at Amazon, Apple, and Samsung. Labs: mHealth Systems Lab, NIH mDOT Center. Leadership roles include Director of MD2K and advisor to NSF Engineering Research Centers.

• Neuromuscular Taping
• Manual Lymphatic Drainage
• Biomechanics Applied to Physiotherapy
• +۷ مورد دیگر

María Jesús Martínez Beltrán is an Adjunct Professor at the School of Nursing and Physiotherapy San Juan de Dios, Pontifical University of Comillas. She holds a Doctorate in Biomedicine and Health Sciences from Universidad Europea de Madrid and has been teaching since 2012, specializing in Physiotherapy, Biomechanics, and Palliative Care. Her research focuses on neuromuscular taping, manual lymphatic drainage, and biomechanical applications in physiotherapy. She has coordinated clinical practices and maintains a Level 2 research classification. Notable contributions include studies on whiplash rehabilitation using AI, aquatic therapy for intellectual disability patients, and biomechanical injury prevention in athletes. Education: Doctor in Biomedicine and Health Sciences, Universidad Europea de Madrid MSc in Applied Biomechanics, Pontifical University of Comillas Bachelor's and Diploma in Physiotherapy, Pontifical University of Comillas Research Interests: Transdisciplinary therapies, cervical spine biomechanics, sports injury prevention, AI in clinical prediction, and palliative care communication. She has published extensively in journals like PLoS One and presented at international conferences such as ESMAC and ISB. Professional Experience: Former Healthcare Director at Fisioterapia Novofisio S.L. (2004-2019) and currently active in academic roles including Master's coordination. Holds ANECA certifications for university-level teaching roles. Labs/Teams: Involved in interdisciplinary projects like the Sperantia.app mental health initiative and HOOPe oncology study. Collaborates with institutions such as the European Society of Movement Analysis and the International Society of Biomechanics.

Sirpa Jalkanenمشاهده پروفایل

استاد

• Immunology
• Molecular Biology
• Cell Biology
• +۷ مورد دیگر

Sirpa Jalkanen is a Professor of Immunology at the University of Turku and a Research Professor at the National Institute of Health and Welfare. She has held leadership roles including Director of the MediCity Research Laboratory and the Receptor Program at Turku University, and Vice Dean of the Medical Faculty (2010-2013). Degrees: M.D. (1979), Ph.D. (1983), Docent in Immunobiology (1987) Speciality: Clinical Microbiology (1990) Her research focuses on endothelial cell biology , lymphocyte trafficking , and transcellular migration . She has pioneered discovery of adhesion molecules and their roles in inflammation, with significant contributions to understanding leukocyte migration and vascular biology. The provided publications (2005-2013) highlight her work on VAP-1 interactions , Siglec receptors , endothelial markers , and lymphatic trafficking . These studies span immunology, molecular biology, and lymphatic system research, revealing mechanisms in leukocyte adhesion and potential diagnostic applications. Scientific Awards: Datta Medal (2011) Äyräpää Prize (2008) Anders Jahre Prize (2005) Elias Lönnrot Medal (2004) Maud Kuistila Prize (1997) Jalkanen has trained 24 thesis students and 21 postdoctoral fellows, five of whom hold professorships or leadership roles. Her work has led to over 242 publications (H-index 55), 10+ patents, and two biotech companies: BioTie Therapies and Faron Pharmaceuticals.

• Public Health
• Implementation Science
• Clinical Trials
• +۷ مورد دیگر

Sonali Munot is a Research Fellow at the Westmead Applied Research Centre within the Faculty of Medicine and Health at the University of Sydney. She is affiliated with the Charles Perkins Centre , focusing on health equity and implementation science.

• Breast Pathology
• Oncologic Pathology
• Genomics
• +۳ مورد دیگر

Lorraine Colón-Cartagena is an Assistant Professor in the Department of Pathology at Yale School of Medicine. Her expertise focuses on oncologic and breast pathology, with particular interest in tumor behavior and histologic features of breast cancers. She completed her residency in Anatomic and Clinical Pathology at Virginia Commonwealth University and fellowships in Oncologic and Breast Pathology at Memorial Sloan Kettering Cancer Center. Education & Training: Residency: Anatomic and Clinical Pathology, Virginia Commonwealth University Fellowship: Oncologic Surgical Pathology, Memorial Sloan Kettering Cancer Center (2022) Fellowship: Breast Pathology, Memorial Sloan Kettering Cancer Center (2023) Research Interests: Dr. Colón-Cartagena’s work explores the genomic and epigenomic basis of breast tumors, metastatic mechanisms in breast cancer, and surgical outcomes in breast oncology. Her research integrates molecular pathology with clinical implications to improve diagnostic accuracy and patient care. Publications: Her recent work includes studies on breast invasive lobular carcinomas, cost analyses of breast-conserving surgeries, and molecular inhibitors targeting metastasis. These publications highlight her focus on translational research bridging basic science and clinical practice. Affiliations: She is affiliated with Yale Cancer Center and contributes to interdisciplinary teams in genomics and breast pathology research.

Nguyen Thanh Thi Kimمشاهده پروفایل

استاد

• Nanomaterials Synthesis
• Biomedical Applications of Nanoparticles
• Magnetic and Plasmonic Nanomaterials
• +۴ مورد دیگر

Prof. Nguyen Thanh Thi Kim is a Full Professor in Nanomaterials and Vice Dean for Innovation and Enterprise at UCL's Faculty of Mathematical & Physical Sciences. She leads research on magnetic/plasmonic nanomaterials for biomedical applications such as MRI contrast agents, cancer therapy, and drug delivery systems. Her work emphasizes scalable synthesis and functionalization of nanoparticles, with a focus on clinical translation. Positions: 2021–Present: Vice Dean for Innovation & Enterprise, UCL 2013–Present: Professor in Nanomaterials, UCL Department of Physics & Astronomy Research Focus: Cutting-edge synthesis of nanoparticles (e.g., iron oxides, gold nanorods) for diagnostics (MRI), therapeutics (hyperthermia, drug delivery), and environmental applications. Key areas include: Biomedical nanomaterials functionalization Magnetic nanoparticle heating mechanisms Continuous-flow manufacturing of nanoparticles Awards: 2023 IUPAC Distinguished Women Award 2023 SCI/RSC Graham Prize 2019 Royal Society Rosalind Franklin Medal 2014 Founder of Vietnam Young Academy Editorial Roles: Editor-in-Chief of Royal Society of Chemistry's Nanoscience & Nanotechnology series, and Associate Editor of Nanoscale . She has edited 7 theme issues and authored/co-authored 2 seminal books on magnetic nanoparticles. Impact: Over 168 publications, 19,743 citations, and 100+ patents/patent applications. Her research bridges academia and industry, notably advancing MRI contrast agents and hyperthermia treatments.

• Nanomedicine
• Drug Delivery Systems
• Pharmaceutical Technology
• +۴ مورد دیگر

Noemi Stefanía Csaba is a Professor at the University of Santiago de Compostela, affiliated with the Department of Pharmacology, Pharmacy and Pharmaceutical Technology within the Faculty of Pharmacy. She is also part of the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS). Her research focuses on nanotechnologies applied to drug delivery systems, particularly in the development of gene therapy carriers, vaccines, and targeted therapies for cancer and infectious diseases. She earned her PhD in 2005 with a thesis on genetic vaccine delivery systems under the supervision of Dr. María José Alonso Fernández and Dr. Alejandro Sánchez Barreiro. Her research interests encompass nanomedicine, biomaterials engineering, and mucosal drug delivery. She has pioneered studies on protamine nanocapsules, chitosan-based systems, and polyphosphazene derivatives for targeted drug delivery. Her work addresses challenges in overcoming biological barriers (e.g., nasal-to-brain, pulmonary, intestinal) and enhancing therapeutic efficacy through nanoparticle design. Notable contributions include the development of semisynthetic pneumococcal nanovaccines, hybrid peptide-polymer platforms for cancer immunotherapy, and lymphatic-targeted anticancer nanocarriers. Her articles highlight advancements in gene delivery for glioblastoma, ocular tumor treatment, and macrophage-targeted pulmonary therapies. While no specific awards are listed, her prolific publication record (spanning 2002–2025) reflects sustained innovation in pharmaceutical nanotechnology. She collaborates widely on projects integrating biomaterials, molecular medicine, and translational drug delivery systems. Her lab (NANOBIOFAR research group) focuses on translational nanomedicine, emphasizing practical applications such as ready-to-use dry powders for pulmonary delivery and plant-derived sporopollenin microcapsules for drug encapsulation. Current work includes optimizing nanoparticle stability, improving vaccine adjuvants, and addressing barriers in intestinal and transmucosal drug absorption.